Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

0.57
Delayed Data
As of Sep 23
 -0.0253 / -4.25%
Today’s Change
0.56
Today|||52-Week Range
1.44
-44.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues4.6M5.8M679.0K1.8M
 
 
 
 
 
Cost of Goods Sold1.4M1.8M7.0K1.2M
 
 
 
 
 
Depreciation And Amortization607.0K588.0K516.0K490.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.6M3.5M156.0K94.0K
 
 
 
 
 
General Expenses8.6M7.5M9.3M12.2M
 
 
 
 
 
Research And Development6.5M5.3M7.3M10.0M
 
 
 
 
 
Total Operating Expenses10.6M9.9M9.9M13.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.0M-4.0M-9.2M-12.1M
 
 
 
 
 
Interest Expense On Debt642.0K1.0M904.0K901.0K
 
 
 
 
 
Other Expenses1.5M1.2M1.3M2.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.1M-3.8M-8.5M-10.7M
 
 
 
 
 
Discontinued Operations0.000.00-72.0K-117.0K
 
 
 
Net Income-5.1M-3.8M-8.6M-10.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS93.6M93.9M99.7M99.8M
 
 
 
 
 
Shares To Calculate EPS Diluted93.6M93.9M99.7M99.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.05-$0.04-$0.09-$0.11
 
 
 
 
 
EPS Diluted-$0.05-$0.04-$0.09-$0.11